Senate Republicans want answers from FDA commish Hamburg on draft guidances

Senate Republicans want answers from FDA commish Hamburg on draft guidances

Four Republican senators are asking FDA commissioner Dr. Margaret Hamburg for some answers on the federal watchdog agency’s practice of issuing draft guidances to cover medical device and drug review policies.

In the May 6 letter the legislators – Sens. Lamar Alexander (R-Tenn.), Richard Burr (R-N.C.), Johnny Isakson (R-Ga.) and Orrin Hatch (R-Utah) – say they’re concerned that the draft guidances are being used by the FDA "to make substantive policy changes."

"Stakeholders tell us that draft guidances are increasingly becoming default FDA policy and position. Draft guidances state that the ‘guidance document is being distributed for comment purposes only.’ However, in the absence of finalized guidance, drafts are the only information that FDA review staff, patients, clinicians, and FDA-regulated entities have on the agency’s most current thinking on important issues," the senators wrote.

Another concern is that "these draft guidances are not being revised, finalized, or withdrawn in a timely manner," according to the letter.

"We believe that public comment from FDA-regulated entities, health care providers, consumers, and patients not only will help shed light on any unintended consequences of the agency’s draft guidance, but better inform and , ultimately, improve that guidance. It is integral that those improvements are reflected in updated guidance documents and the guidance is being appropriately and consistently applied by product reviewers," according to the letter.

The senators also said they’re worried that some of the draft guidances don’t seem to take into account, or even conflict with, current scientific thinking. They want Hamburg to send them a list of all Level 1 draft guidances, their date of issue and the timeline for withdrawal, revision or finalization of each one. Alexander, Burr, Isakson and Hatch also want an update on the FDA’s implementation of the best practices recommended in a 2011 report, "Food & Drug Administration Report on Good Guidance Practices: Improving Efficiency and Transparency."

They also want Hamburg to tell them whether her agency has implemented a recommendation from President Barack Obama’s Council of Advisors on Science & Technology "to rely more on the biomedical community in help [sic] developing and revising guidances." The senators asked Hamburg how she ensures that FDA staffers don’t rely on draft guidance "in the absence of any other policy or final guidance;" they also want to know the average time it took the FDA to finalize draft guidances issued over the last 5 years, according to the letter.

\

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Comments

  1. says

    I simply want to say I am just very new to blogging and site-building and actually liked this web-site. Very likely I’m planning to bookmark your site . You definitely have incredible writings. Bless you for sharing your webpage.

Trackbacks

  1. Hi, nice to see your website

    Apakah agan wati membutuhkan obat herbal de Nature Indonesia silahkan bisa hubungi customer service kami secara langsung via SMS ataupun Telepon. Kami selalu online 24 jam untuk melayani pemesanan produk herbal de Nature.

  2. … [Trackback]

    […] Read More here: massdevice.com/senate-republicans-want-answers-fda-commish-hamburg-draft-guidances/ […]

  3. Hi, nice to see your website

    Apakah bapak membutuhkan obat herbal de Nature Indonesia silahkan dapat hubungi customer service kita secara langsung lewat SMS ataupun Telepon. Kami selalu online 24 jam utk melayani pembelian obat herbal de Nature.

  4. Hi, nice to see your website

    Apakah kamu membutuhkan obat herbal de Nature Indonesia silahkan dapat hubungi customer service kita secara langsung melalui SMS ataupun Telepon. Kami selalu online 24 jam utk melayani pembelian obat herbal de Nature.

Leave a Reply